The effect of KLF4 and Nanog expression on spheroid formation, and responses to cisplatin and TRAIL treatments, was investigated by either silencing or overexpressing their expression in two gastric cancer cells, SNU-601 (KLF4/Nanog-high) and SNU-638 (KLF4/Nanog-low). The gene discussed is NANOG; the disease is gastric cancer.